TNGX
Tango Therapeutics Inc
22.60$
+3.4%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.7% | +1.3% | +1.1% | -1.6% | -0.3% | +0.3% | +0.5% | -11.2% | -13.7% | -3.3% | -8.2% | – | |
| – | +0.4% | +37.7% | +12.2% | -4.8% | +4.0% | -2.8% | -9.4% | +0.8% | -9.7% | +80.6% | +56.5% | – | |
| – | – | – | – | – | – | – | – | – | – | -518.3% | – | – | |
| – | +1,312.5% | -13.7% | +64.1% | -64.1% | +7.8% | -58.9% | +1,123.5% | -75.8% | +47.0% | -99.1% | -100.0% | – | |
| – | – | -133.1% | – | +156.5% | +59.8% | -41.2% | -45.2% | +183.0% | -385.9% | – | -4,728.7% | – | |
| – | -98.2% | +2,829.9% | -96.9% | +83.2% | -59.7% | -99.8% | +28,950.0% | +337.3% | +8,533.5% | -63.6% | +742.3% | – | |
| – | – | -177.4% | – | – | +935.5% | -167.7% | – | – | +182.9% | -16.4% | +316.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.